292 related articles for article (PubMed ID: 19108040)
1. Dendritic cell immunobiology and potential roles in immunotherapy.
Fadilah SA; Cheong SK
Malays J Pathol; 2007 Jun; 29(1):1-18. PubMed ID: 19108040
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of dendritic cell-based vaccination against infection.
Fajardo-Moser M; Berzel S; Moll H
Int J Med Microbiol; 2008 Jan; 298(1-2):11-20. PubMed ID: 17719274
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based cancer immunotherapies.
Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
[TBL] [Abstract][Full Text] [Related]
4. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.
O'Neill D; Bhardwaj N
Methods Mol Med; 2005; 109():1-18. PubMed ID: 15585909
[TBL] [Abstract][Full Text] [Related]
5. [Dendritic cells for cancer immunotherapy].
Kakimi K; Kondo A; Matsushita H
Nihon Rinsho; 2012 Dec; 70(12):2130-5. PubMed ID: 23259385
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells and autoimmunity.
Bayry J; Thirion M; Delignat S; Misra N; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Autoimmun Rev; 2004 Mar; 3(3):183-7. PubMed ID: 15110229
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell vaccines in melanoma: from promise to proof?
Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?
Cools N; Petrizzo A; Smits E; Buonaguro FM; Tornesello ML; Berneman Z; Buonaguro L
Immunotherapy; 2011 Oct; 3(10):1203-22. PubMed ID: 21995572
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells: understanding immunogenicity.
Steinman RM
Eur J Immunol; 2007 Nov; 37 Suppl 1():S53-60. PubMed ID: 17972346
[TBL] [Abstract][Full Text] [Related]
10. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.
Ehser S; Chuang JJ; Kleist C; Sandra-Petrescu F; Iancu M; Wang D; Opelz G; Terness P
Hum Immunol; 2008 Mar; 69(3):165-73. PubMed ID: 18396208
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
12. [Role of immunity and tolerance in renal diseases].
Ranieri E
G Ital Nefrol; 2005; 22(2):140-51. PubMed ID: 15875277
[TBL] [Abstract][Full Text] [Related]
13. The cross-talk between dendritic and regulatory T cells: good or evil?
Hubert P; Jacobs N; Caberg JH; Boniver J; Delvenne P
J Leukoc Biol; 2007 Oct; 82(4):781-94. PubMed ID: 17652446
[TBL] [Abstract][Full Text] [Related]
14. Current issues in dendritic cell cancer immunotherapy.
López JA; Hart DN
Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
[TBL] [Abstract][Full Text] [Related]
15. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.
Schott M
Endocr Relat Cancer; 2006 Sep; 13(3):779-95. PubMed ID: 16954430
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?
Lebre MC; Tak PP
Hum Immunol; 2009 May; 70(5):321-4. PubMed ID: 19236901
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell biology and cancer therapy.
Whiteside TL; Odoux C
Cancer Immunol Immunother; 2004 Mar; 53(3):240-8. PubMed ID: 14685779
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritis.
Wenink MH; Han W; Toes RE; Radstake TR
Handb Exp Pharmacol; 2009; (188):81-98. PubMed ID: 19031022
[TBL] [Abstract][Full Text] [Related]
19. Harnessing dendritic cells for immunotherapy.
Delamarre L; Mellman I
Semin Immunol; 2011 Feb; 23(1):2-11. PubMed ID: 21377379
[TBL] [Abstract][Full Text] [Related]
20. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
